Despite the high incidence of brain metastasis after resection of non-small cell lung cancer (NSCLC), the National Comprehensive Cancer Network guidelines do not recommend central nervous system (CNS) ...
The battle against drug resistance in lung cancer therapy remains a critical issue in oncology, with resistance mechanisms ...
Lung cancer remains one of the most widespread and deadliest malignant tumors globally, with a particularly high mortality rate among all cancers. Recently, immunotherapy, particularly immune ...
A multivariate analysis confirmed the independent prognostic significance of both landmark and longitudinal MRD.
Targeted therapies have significantly improved outcomes for patients with non-small cell lung cancer (NSCLC) with actionable mutations. However, many tumors inevitably develop drug resistance and ...
Findings on golidocitinib for patients with non-small cell lung cancer whose disease has progressed on anti-PD-1 therapy will ...
Annual lung cancer screening, or LCS, detects cancer at a higher rate and at earlier stages, findings suggest.According to Roger Y. Kim, MD, MSCE, DAABIP, ATSF, an assistant professor of medicine at ...
The test works by looking for cell-free nucleosomes in the blood. The study included 229 patients diagnosed with cancer and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback